Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
JAMA Dermatology|April 3, 2020
Changes in Disease Activity and Damage Over Time in Patients With MorpheaJack C O'Brien, Hugh Nymeyer, Allison Green, et al.The Journal of Physical Chemistry. B|May 28, 2009
Energy landscape of the trpzip2 peptideHugh NymeyerThe British Journal of Dermatology|July 15, 2025
Validation of CXCL9 as a biomarker of morphea disease state and severity through longitudinal analysisHenry W Chen, Grant Barber, Jennifer Foster, et al.Journal of Chemical Theory and Computation|December 2, 2015
How Efficient Is Replica Exchange Molecular Dynamics? An Analytic ApproachHugh NymeyerBiophysical Journal|July 4, 2006
Indole localization in lipid membranes revealed by molecular simulationKristen E Norman, Hugh NymeyerProceedings of the National Academy of Sciences of the United States of America|November 18, 2003
Simulation of the folding equilibrium of alpha-helical peptides: a comparison of the generalized Born approximation with explicit solventHugh Nymeyer, Angel E GarcíaBiophysical Journal|October 24, 2007
A method to determine dielectric constants in nonhomogeneous systems: application to biological membranesHugh Nymeyer, Huan-Xiang ZhouThe Journal of Investigative Dermatology|April 29, 2017
Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in MorpheaJack C O'Brien, Yevgeniya Byekova Rainwater, Neeta Malviya, et al.Journal of the American Academy of Dermatology|June 8, 2011
A systematic review of morphea treatments and therapeutic algorithmBrittany A Zwischenberger, Heidi T JacobePageof 9